Portfolio Category: Diagnostics

Cavos Biotech is an emerging genomic and data science company focusing on the development of novel drugs based on naturally occurring resistance mechanisms for various diseases. We are developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found in specific, and across various animals. We harness the genomic and data revolution and use high resolution identification methods to uncover existing anti-cancer mechanisms, and novel drug targets, and to revolutionize the way by which drug targets are discovered and identified.

Senseera’s technology ushers a new generation of liquid biopsy blood tests providing unparalleled information about disease processes in the patient’s internal organs and immune system with a single blood test. Senseera’s mission is to transform disease diagnosis and treatment and to enhance development of new therapeutics.

Established in 2016, Salignostics has developed a novel technology which utilizes saliva for lateral flow immunoassay applications. Our vision is to transform the next generation of in-vitro diagnostics by developing easy, clean, safe, low-cost, accessible and reliable saliva-based products.

Our novel droplet technology provides enhanced bio-availability for both anterior and posterior segments of the eye. High solubility capacity transcends traditional limitations of size and polarity. the ability to achieve higher concentrations of known APIs enables treatment of severe cases, Improved safety and efficacy,reduced treatment burden, and targeted delivery capability enables topical treatment for posterior segment diseases like age related macular degeneration.